Geographical similarity and differences in the burden and genetic predisposition of NAFLD

TCF Yip, E Vilar‐Gomez, S Petta, Y Yilmaz… - Hepatology, 2023 - journals.lww.com
NAFLD has become a major public health problem for more than 2 decades with a growing
prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease …

Metabolic dysfunction-associated fatty liver disease: a year in review

J Alharthi, A Gastaldelli, IH Cua… - Current Opinion in …, 2022 - journals.lww.com
The transformation in name and definition from NAFLD to MAFLD represents an important
milestone, which indicates significant tangible progress towards a more inclusive, equitable …

MAFLD predicts the risk of cardiovascular disease better than NAFLD in asymptomatic subjects with health check-ups

H Kim, CJ Lee, SH Ahn, KS Lee, BK Lee… - Digestive diseases and …, 2022 - Springer
Abstract Background and Aim Metabolic dysfunction-associated fatty liver disease (MAFLD)
was proposed to compensate for the conventional concept of nonalcoholic fatty liver disease …

Screening for MAFLD: who, when and how?

SC Pal, N Méndez-Sánchez - Therapeutic Advances in …, 2023 - journals.sagepub.com
Metabolic-associated fatty liver disease (MAFLD) is a highly prevalent disease with
increasing prevalence worldwide. Currently, no universal screening methods have been …

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease

E Kaya, Y Yilmaz - Therapeutic Advances in Endocrinology …, 2022 - journals.sagepub.com
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic
liver disease worldwide–with an estimated global prevalence of 37%. Different from …

Prevalence of non-alcoholic fatty liver disease in the Russian Ural Eye and Medical Study and the Ural Very Old Study

MM Bikbov, TR Gilmanshin, RM Zainullin… - Scientific Reports, 2022 - nature.com
Abstract Information about prevalence and associated factors of non-alcoholic fatty liver
disease (NAFLD) has been scarce for the Russian, Eastern European and Central Asian …

[HTML][HTML] Community-centered disease severity assessment of metabolic dysfunction-associated fatty liver disease

JF Huang, PC Tsai, ML Yeh, CF Huang… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Methods This multicenter cross-sectional study enrolled adults participating in liver disease
screening in the community. Patients were stratified following MAFLD diagnostic criteria, to …

Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study

I Ergenc, E Kara, ME Yilmaz, CO Demirtas… - Heliyon, 2024 - cell.com
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) is a
growing global epidemic in Türkiye and worldwide. The aim of this study was to evaluate the …

[HTML][HTML] TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease

Y Yilmaz, M Zeybel, G Adali, AM Cosar… - Hepatology …, 2023 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly
associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome …

Effects of Cornus mas L. on anthropometric and biochemical parameters among metabolic associated fatty liver disease patients: Randomized clinical trial

HM Bayram, R Iliaz, FE Gunes - Journal of Ethnopharmacology, 2024 - Elsevier
Ethnopharmacological relevance Cornus mas L.(Cornelian cherry, CM) fruits have been
utilized for decades in numerous European and Asian countries as traditional cuisine and …